Behavioral Effects of d-Amphetamine in Humans: Influence of Subclinical Levels of Inattention and Hyperactivity

被引:3
|
作者
Sevak, Rajkumar J.
Stoops, William W.
Rush, Craig R. [1 ,2 ,3 ]
机构
[1] Univ Kentucky, Albert B Chandler Med Ctr, Dept Behav Sci, Coll Med, Lexington, KY 40536 USA
[2] Univ Kentucky, Albert B Chandler Med Ctr, Dept Psychiat, Lexington, KY 40536 USA
[3] Univ Kentucky, Dept Psychol, Lexington, KY 40536 USA
关键词
substance abuse; attention-deficit hyperactivity disorder; behavior; d-amphetamine; hyperactivity; inattention; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DISCRIMINATIVE-STIMULUS; SUBSTANCE USE; METHYLPHENIDATE; TRIAZOLAM; ABUSE; METHAMPHETAMINE; DEPENDENCE; NICOTINE; SYMPTOMS;
D O I
10.3109/00952990.2010.494213
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: Several studies suggest a link between stimulant abuse and attention-deficit hyperactivity disorder (ADHD) symptoms (e. g., inattention and hyperactivity). To further assess the nature of this relationship, the present study examined the association between subclinical symptoms of inattention and hyperactivity and the behavioral effects of d-amphetamine. Methods: Participants were classified into a High-(n = 8) or Low-Score (n = 9) group based on their responses on a rating scale that assessed inattention and hyperactivity symptoms. Results: The participants did not differ across the High-Score and Low-Score groups in their ability to discriminate d-amphetamine. The participants in the High-Score group were significantly more sensitive to the positive participant-rated effects of d-amphetamine (e. g., Good Effects, Like Drug), but less sensitive to drug-induced increases in blood pressure and heart rate. Conclusion: The selective increase in positive subjective effects of d-amphetamine suggests that individuals with subclinical inattention and hyperactivity symptoms may have increased vulnerability to stimulant abuse.
引用
收藏
页码:220 / 227
页数:8
相关论文
共 50 条
  • [31] Behavioral effects of bidirectional modulators of brain monoamines reserpine and d-amphetamine in zebrafish
    Kyzar, Evan
    Stewart, Adam Michael
    Landsman, Samuel
    Collins, Christopher
    Gebhardt, Michael
    Robinson, Kyle
    Kalueff, Allan V.
    BRAIN RESEARCH, 2013, 1527 : 108 - 116
  • [32] What is a "low dose" of d-amphetamine for inducing behavioral effects in laboratory rats?
    Grilly, DM
    Loveland, A
    PSYCHOPHARMACOLOGY, 2001, 153 (02) : 155 - 169
  • [33] Reinforcing, subject-rated performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans
    Stoops, WW
    Glaser, PEA
    Fillmore, MT
    Rush, CR
    JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (04) : 534 - 543
  • [34] Does COMT genotype influence the effects of d-amphetamine on executive functioning?
    Wardle, M. C.
    Hart, A. B.
    Palmer, A. A.
    de Wit, H.
    GENES BRAIN AND BEHAVIOR, 2013, 12 (01) : 13 - 20
  • [35] SUBTLE VARIATIONS IN LIVING-CONDITIONS INFLUENCE BEHAVIORAL-RESPONSE TO D-AMPHETAMINE
    EXNER, M
    CLARK, D
    NEUROREPORT, 1993, 4 (08) : 1059 - 1062
  • [36] Intranasal Methamphetamine Self-administration in Humans During D-amphetamine Maintenance
    Glaser, Paul
    Pike, Erika
    Hays, Lon
    Stoops, William W.
    Rush, Craig R.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S528 - S528
  • [37] Reinforcer magnitude affects delay discounting and influences effects of d-amphetamine in rats
    Krebs, Christopher A.
    Reilly, William J.
    Anderson, Karen G.
    BEHAVIOURAL PROCESSES, 2016, 130 : 39 - 45
  • [38] Caffeine choice prospectively predicts positive subjective effects of caffeine and d-amphetamine
    Sigmon, Stacey C.
    Griffiths, Roland R.
    DRUG AND ALCOHOL DEPENDENCE, 2011, 118 (2-3) : 341 - 348
  • [39] Effect of d-amphetamine on prepulse inhibition of the startle reflex in humans
    Hutchison, KE
    Swift, R
    PSYCHOPHARMACOLOGY, 1999, 143 (04) : 394 - 400
  • [40] Effects of chronic d-amphetamine administration on the reinforcing strength of cocaine in rhesus monkeys
    Czoty, Paul W.
    Martelle, Jennifer L.
    Nader, Michael A.
    PSYCHOPHARMACOLOGY, 2010, 209 (04) : 375 - 382